Reducing Filth Fly Populations and Transmission of Diarrhoeal Pathogens in Harsh Settings
NCT07272122 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 5676
Last updated 2025-12-09
Summary
Objectives The main trial objective is to evaluate the efficacy of insecticidal paint (PAINT) or larvicide (LARV), or both interventions combined, on filth fly density and hence transmission of diarrhoeal diseases.
Primary Objective
• To evaluate the efficacy of PAINT or LARV, or both interventions combined, in reducing the number of cases of all-cause diarrhoea (primary epidemiological endpoint).
Secondary Objectives
* To evaluate the efficacy of PAINT or LARV, or both interventions combined, in reducing filth fly density and species composition at the latrine level (primary entomological endpoint).
* To evaluate the efficacy of PAINT or LARV, or both interventions combined, in reducing filth fly density and species composition at the shelter level (secondary entomological endpoint).
Tertiary Objectives
* To assess the impact of PAINT or LARV, or both interventions combined, on enteric pathogen species composition and density (tertiary entomological endpoint).
* To assess the impact of PAINT or LARV, or both interventions combined, on enteric pathogen antimicrobial resistance (AMR) prevalence (tertiary entomological endpoint).
Trial Design The proposed trial will be a 3-period, 3-group, interventional non-randomized cross-over trial with parallel control (Table 1). The unit of intervention will be an individual refugee camp. Each implementation phase will be 6 months, followed by a 2-month wash-out period.
The trial arms will be:
1. No intervention (control arm)
2. Inesfly® Carbapaint 10 insecticidal paint (intervention arm 1)
3. Dimilin® larvicide (intervention arm 2)
Conditions
- Diarrheal Diseases
Interventions
- OTHER
-
Long-lasting insecticidal paint - 1.0% (w/w) propoxur
Inesfly® Carbapaint 10 (Inesfly Corporation, Valencia, Spain) is a water-based polymer coating containing a microencapsulated suspension of 1.0% (w/w) propoxur (carbamate), for slow release to prolong efficacy. Propoxur is a non-repellent active ingredient (AI) and when used on pit latrine walls, flies will land on the surface and receive a lethal insecticidal dose. All eligible pit latrines assigned to this intervention arm will be treated with Inesfly® Carbapaint 10 at the beginning of each 6-month implementation phase; pit latrines with at least 3 standing walls, will be eligible.
- OTHER
-
Insect growth regulator (IGR) - effervescent granule containing 2% diflubenzuron (20g/kg)
This intervention will interrupt filth fly development at the larval / pupal stage, to reduce overall population density. All eligible pit latrines (with at least 3 standing walls) assigned to this intervention arm will be treated with Dimilin® GR-2 at 0.5 kg/10m2; granules will be sprinkled onto damp sewage per pit latrine. If waste is desiccated, this intervention will be diluted in water and applied as a spray. This intervention will be re-applied to pit latrines and open defecation sites, every month during each 6-month implementation phase.
Sponsors & Collaborators
-
University of Nevada, Las Vegas
collaborator OTHER -
The Mentor Initiative
lead OTHER
Principal Investigators
-
Richard J Allan, PhD · The Mentor Initiative
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-12-10
- Primary Completion
- 2027-10-31
- Completion
- 2027-12-19
Countries
- South Sudan
Study Locations
More Related Trials
-
Efficacy of iOWH032 in Dehydrating Cholera
NCT02111304 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )
NCT03676140 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of IVM/ALB Co-administration
NCT03527732 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Monitoring the Efficacy of Anthelmintics for the Treatment of Soil Transmitted Helminths P2
NCT01379326 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Alternative Treatment Strategies and Delivery Systems for Soil-transmitted Helminths in Kenya
NCT02397772 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Pediculosis (Head Lice) in Senegal
NCT03578679 ·Status: COMPLETED ·Phase: NA
-
A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis
NCT03341767 ·Status: TERMINATED ·Phase: PHASE2
-
Poultry Management and Child Diarrhea in Uganda
NCT04580212 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi
NCT01213576 ·Status: TERMINATED ·Phase: NA
-
A Pilot Study Examining for the Presence of Fecal Coliforms and Tropical Diseases in Peru
NCT03078894 ·Status: UNKNOWN
-
Treatment of Strongyloides Infection
NCT03605758 ·Status: TERMINATED ·Phase: PHASE3
-
Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin
NCT03570814 ·Status: COMPLETED ·Phase: PHASE4
-
Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNG
NCT03268252 ·Status: COMPLETED
-
A Community Trial to Determine Whether 'Safe Storage' Reduces Pesticide Self-poisoning in Rural Asia
NCT01146496 ·Status: COMPLETED ·Phase: NA
-
The Effect of a Deworming Intervention to Improve Early Childhood Growth and Development in Resource-poor Areas
NCT01314937 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating the Impact of Community Led Total Sanitation Programs in Mali
NCT01900912 ·Status: COMPLETED ·Phase: NA
-
Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus Infection
NCT04913610 ·Status: TERMINATED ·Phase: PHASE2
-
Water-based Zinc Intervention Trial in Zinc Deficient Children
NCT01472211 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense
NCT03974178 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults
NCT03910972 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tolerability and Acceptability of Fibersol-2 in Children
NCT03565393 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Incidences, Causes, and Outcomes of Febrile Illness in Rural South and Southeast Asia
NCT04478578 ·Status: RECRUITING
-
Single Dose Azithromycin to Prevent Cholera in Children
NCT04326478 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Spillover Effects of Water, Sanitation, and Hygiene Interventions on Child Health
NCT02396407 ·Status: COMPLETED ·Phase: NA
-
Pakistan Flocculent Health Outcome Study
NCT01538953 ·Status: COMPLETED ·Phase: NA